Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis

References

• Organization WH. Global hepatitis report, 2017.
   Google Scholar
• Liaw YF, Chu CM. Hepatitis B virus infection. Lancet (London, England). 2009 Feb 14;373(9663):582–592. doi:10.1016/S0140-6736(09)60207-5.
   PubMed Web of Science ®Google Scholar
• Cui F, Shen L, Li L, Wang H, Bi S, Liu J, Zhang G, Wang F, Zhang H, Sun X, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–772. doi:10.3201/eid2305.161477.
   PubMed Web of Science ®Google Scholar
• Chen W. Epidemiological survey of 7119 patients with chronic hepatitis B. Chin J Nosocomiology. 2010;20(5):655. (In Chinese).
   Google Scholar
• Daniels D, Grytdal S, Wasley A. Surveillance for acute viral hepatitis - United States, 2007. Morbidity Mortality Weekly Rep Surveill Summ. 2009;58(3):1.
   PubMedGoogle Scholar
• Bridges CB, Woods L, Coyne-Beasley T. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older—United States, 2013. Morbidity Mortality Weekly Rep Surveill Summ. 2013;62 Suppl 1(5):9.
   Google Scholar
• Bonanni P. 1995. Implementation in Italy of a universal vaccination programme against hepatitis B. Vaccine. 13:S68–S71. doi:10.1016/0264-410X(95)80058-L.
   PubMed Web of Science ®Google Scholar
• Zuckerman J, Langer B. Hepatitis B vaccination in a school age population: a feasibility study. J Med Virol. 2005;76(1):47–54. doi:10.1002/jmv.20372.
   PubMed Web of Science ®Google Scholar
• Li J, Yao J, Shan H, Chen Y, Jiang ZG, Ren JJ, Xu K, Ruan B, Yang S, Wang B, et al. Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults. Hum Vaccin Immunother. 2015;11(5):1108–1113. doi:10.4161/21645515.2014.988547.
   PubMed Web of Science ®Google Scholar
• Banatvala J, Damme PV, Oehen S. Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory. Vaccine. 2000;19(7–8):877.
   PubMed Web of Science ®Google Scholar
• Hammitt L, Hennessy T, Fiore A, Zanis C, Hummel K, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine. 2007;25(39–40):6958–6964. doi:10.1016/j.vaccine.2007.06.059.
   PubMed Web of Science ®Google Scholar
• Kang G, Ma F, Chen H, Yang Y, Guo S, Wang Z, et al. Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers. Vaccine. 2015;33(33):4093. doi:10.1016/j.vaccine.2015.06.081.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang W, Lyu JJ, Zhang JJ, Liu JY, Yan BY,  et al. [Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up]. Chin J Epidemiol. 2017;38(9):1156. (In Chinese).
   Google Scholar
• Chen YZ, Jiang RJ, Shen JJ, Chen CB, Zhou CL, Tang Q, et al. Study on the immunization schedule and dose of genetic recombinant hepatitis B vaccine wed for adults. Chin J Vaccines Immunization. 2005;11(02):100–105. (In Chinese).
   Google Scholar
• Zhang W, Han L, Lin C, Wang H, Pang X, Li L, et al. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine. Vaccine. 2011;29(37):6276–6282. doi:10.1016/j.vaccine.2011.06.045.
   PubMed Web of Science ®Google Scholar
• Liu C, Tang Y, Wang R, Sui J, Cai X, Zhang W. Evaluation of the immune effect of Chinese hamster ovary cell derived hepatitis B vaccine among adults. Chin J Prev Med. 2012;(09):701–703. (In Chinese).
   Google Scholar
• Xu M, Niu Z, Yu J, Gao S, He L, Ye Y. Immunogenicity of different doses or areas of recombinant yeast-derived hepatitis B vaccine on the youth. Mod Prev Med. 2013;(15):2905–2906. (In Chinese).
   Google Scholar
• Xing W, Liu C, Tang Y, Wang R, Xu Z, Zhang W. Evaluation on effect of different doses of domestic recombinant yeast-derived hepatitis B vaccine on adult immunization. Occup Health. 2014;(01):88–89+93. (In Chinese).
   Google Scholar
• Huang X. The immune effect of different doses of hepatitis b vaccine in adult immunization. Chin J Clin Rational Drug Use. 2016;(35):59–60. (In Chinese).
   Google Scholar
• Liu J, Yan B, Zhang L, Lv J, Feng Y, Ji F. Comparison on the antibody response and influenced factors of hepatitis B vaccine made by recombinant deoxyribonucleic acid techniques among adults. Chin J Vaccines Immunization. 2013;(02):142–146+153. (In Chinese).
   Google Scholar
• Wang H, Cai B, Rao D, Liu M, Li Y, Liang X. Rapid immunization effects of a new type of 60 mug hepatitis B vaccine compared with traditional 20 mug hepatitis B vaccines in adults. Hum Vaccines and Immunotherapeutics. 2016;12(11):2921–2926. doi:10.1080/21645515.2016.1206676.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zheng X, Wang Z, Yu S. The effect and safety of different doses of recombinant yeast hepatitis b vaccine on adult immunity. Chin J Infect Dis. 2003;(06):46–47. (In Chinese).
   Google Scholar
• Yu S, Ling J, Qian X, Hu Z, Liu T Three adult immunization schedules of hepatitis B vaccine. Paper presented at: Disease Surveillance 2012. (In Chinese)
   Google Scholar
• Cao Y. Analysis of the immune response in adults vaccinated with 20 micrograms of recombinant hepatitis B. J Pathog Biol. 2016;11(05):444–447. (In Chinese).
   Google Scholar
• Chen WG, Ye SD, Jia GF, Tian CS, Luo X. The immune effect of genetic recombinant hepatitis B vaccine made by Chinese hamster ovary cells (CHO). Dis Surveill. 2001;(06):214–216. (In Chinese).
   Google Scholar
• Wang C, Feng Z, Diao L, Zhang Y, Dong C, Li M. The immune effect of adult vaccine with recombinant yeast-derived hepatitis B vaccine made in China. Chin J Health Lab Technol. 2002;(06):702. (In Chinese).
   Google Scholar
• Li W, Li B, Liang X, Wang H, Zhou H, Bao H. Evaluation of immune effect of recombinant hepatitis B vaccine with different doses. J Jilin University (Medicine Edition). 2008;34(06):1050–1053. (In Chinese).
   Google Scholar
• Dong MH, Lin YT, Qian YH, Jiang Y, Deng Y, Ding S, et al. Immunity effect of homemade recombinant yeast-derived hepatitis B vaccine in adults. Mod Med J China. 2009;11(2):24–26. (In Chinese).
   Google Scholar
• Ji X, Liu J, Liu Z, Liu S, Zhnag Y. Observation of immunity effectiveness of different recombinant hepatitis B in adult population. Chin J Public Health Manag. 2009;(06):653–654. (In Chinese).
   Google Scholar
• Guo Y, Liu Q, Xu J, Fan J, Ye Y, Feng X, et al. Study on the immune effects of CHO 20 micrograms Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults. Chin J Dis Control Prev. 2013;17(11):967–970. (In Chinese).
   Google Scholar
• Xu F, He F, Zhou B, Zhao Q, Yan R. Observation on immunization effect of hepatitis B vaccine in adults by different dosages and schedules. Dis Surveill. 2013;(01):38–41. (In Chinese).
   Google Scholar
• Huang X, Fang S, Song X, Wu W, Li R, Guo S. Evaluation of the immunization effect and safety of different domestic hepatitis B vaccines. Mod Prev Med. 2014;(20):3781–3783. (In Chinese).
   Google Scholar
• Song J, Kang G, Wang Y, Dong C, Ma F, Guo S, et al. Immunogenicity and safety of 20 microgram dosages of hepatitis B vaccine by recombinant deoxyribonucleic acid techniques in saccharomyces cerevisiae yeast among low- and non- response populations aged 16 and over. Chin J Vaccines Immunization. 2014;b(04):299–304. (In Chinese).
   Google Scholar
• Zhang L, Liu J, Lu J, Yan B, Song L, Li L, et al. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China. Hum Vaccin Immunother. 2015;11(11):2716–2722. doi:10.1080/21645515.2015.1045172.
   PubMed Web of Science ®Google Scholar
• Fu Q, Chen H, Zhou Q, Chen X, et al. Safety and immunogenicity of hepatitis B vaccine made by recombinant deoxyribonucleic acid techniques in saccharomyces cerevisiae yeast (20ug/ml) in healthy people aged ≥ 16. Chin J Vaccines Immunization. 2015;21(01):72–76+116. (In Chinese).
   Google Scholar
• Guo M, Yao J, Li J. An observation on the immune effect of hepatitis B vaccine by different immunization schedules among adults. Zhejiang J Prev Med. 2015;(08):757–760. (In Chinese).
   Google Scholar
• Zhou B, Xu F, Zhang Y, Yao J. Comparison of effect on immunization schedules of recombinant hepatitis B Vaccine (Hansenula polymorpha) in adults. Chin J Vaccines Immunization. 2015;(05):495–498. (In Chinese).
   Google Scholar
• Zhou Y, Yang L, Li L. Immunization effect of Chinese hamster ovary (CHO) cell hepatitis B vaccine with different schedules in adults. Dis Surveill. 2015;(3):180–183. (In Chinese).
   Google Scholar
• Yang L, Yao J, Li J, Chen Y, Jiang ZG, Ren JJ,  et al. Suitable hepatitis B vaccine for adult immunization in China. Immunol Res. 2016 Feb;64(1):242–250. doi:10.1007/s12026-015-8742-1.
   PubMed Web of Science ®Google Scholar
• Wen Q. Analysis of immune effect and safety of different procedures of adult hepatitis B vaccinations. China Health Ind. 2017;(02):40–41. (In Chinese).
   Google Scholar
• Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. 2016;6:27251. doi:10.1038/srep27251.
   PubMed Web of Science ®Google Scholar
• Ott J, Stevens G, Wiersma S. 2012. The risk of perinatal hepatitis B virus transmission: hepatitis B e antigen (HBeAg) prevalence estimates for all world regions. BMC Infect Dis. 12:131. doi:10.1186/1471-2334-12-166.
   PubMed Web of Science ®Google Scholar
• Chen SY, Wang XC, Dong XL, Xu HT, Wang FD, Tang ZF, et al. Effects of two immunization schedules of recombinant yeast-derived hepatitis B vaccine for adults. Chin Prev Med. 2013;14(02):96–98. (In Chinese).
   Google Scholar
• Organization WH. Hepatitis B vaccines: WHO position paper – july 2017. Releve Epidemiologique Hebdomadaire. 2017;92(27):369.
   PubMedGoogle Scholar
• Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR. Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports. 2006;55(RR–16):1–33.
   PubMedGoogle Scholar
• Velu V, Nandakumar S, Shanmugam S, Shankar EM, Thangavel S, Kulkarni PS, et al. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Pediatr Infect Dis J. 2007;26(11):1038–1041. doi:10.1097/INF.0b013e3181342887.
   PubMed Web of Science ®Google Scholar
• Chiaramonte M, Majori S, Ngatchu T, Moschen ME, Baldo V, Renzulli G, et al. Two different dosages of yeast derived recombinant hepatitis B vaccines: a comparison of immunogenicity. Vaccine. 1996;14(2):135–137.
   PubMed Web of Science ®Google Scholar
• Gerlich WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol. 2015;204(1):39–55. doi:10.1007/s00430-014-0373-y.
   PubMed Web of Science ®Google Scholar
• JiangBo W. A brief history of hepatitis b vaccine development. Chin J Microbiol Immunol. 2013;33(1). (In Chinese).
   Google Scholar
• Yang H, Chen L, Huang J, Liang X, Chen X. Study of domestic and imported recombinant Hepatitis B vaccine safety. J Med Theory Pract. 2015;(2):141–142. (In Chinese).
   Google Scholar
• Fang J, Sun L, Liu J, Rong J, Hu B, Fu C. A study on the immunological effect of recombinant hepatitis B vaccine domestic and import. Chin J Prev Med. 2012;(7). (In Chinese).
   Google Scholar
• Yao J, Li J, Chen Y, Shan H, Dai XW, Yang LN, et al. The response of hepatitis B vaccination on seronegative adults with different vaccination schedules. Hum Vaccin Immunother. 2015;11(5):1102–1107. doi:10.4161/21645515.2014.985500.
   PubMed Web of Science ®Google Scholar
• Casp UK. Critical appraisal skills programme (CASP): checklists. 2013. https://casp-uk.net/casp-tools-checklists/
   Google Scholar
• Chalmers TC, Smith H, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2(1):31–49.
   PubMedGoogle Scholar
• Higgins J, Green S Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration. 2013.
   Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
   PubMedGoogle Scholar
• Moseley AM, Herbert RD, Sherrington C, Maher CG. Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro). Aust J Physiother. 2002;48(1):43–49.
   PubMed Web of Science ®Google Scholar